• profile
  • History
  • Business Model
    • Portfolio Model
    • Licensing
  • Management Team
  • Board of Directors
  • Consultative Committee
  • Professional Affiliations

• products
  • Nimotuzumab
    • Science
    • Safety Profile
    • Clinical Trials
    • Consortium
    • Licensee Links
  • AeroLEF®
    • Science
    • Variable Dosing
    • Clinical Trials
  • CYT387
    • Science
    • Clinical Trials
  • CYT997
    • Science
    • Clinical Trials
  • Clinical Trials
  • Request Medical Info

• investors
  • Financial Reports
  • Regulatory Filings
  • Stock Information
  • Press Releases
  • Calendar of Events
  • Presentations
  • Corporate Governance
  • Investor Contacts
  • Email Sign-up
  • F.A.Q.

• patients
  • Nimotuzumab
    • Patients - Canada
    • Patients - USA
    • Patients - Worldwide
  • CYT387
  • CYT997
  • AeroLEF®

• physicians
  • Nimotuzumab
  • CYT387
  • CYT997
  • AeroLEF®

• contact
  • Investor Contacts
  • Licensing Contact
  • Clinical Contact

Licensing Contact

Sean Thompson
Vice President, Corporate Development & General Manager, IntelliMab™
YM BioSciences Inc.
5045 Orbitor Drive
Building 11, Suite 400
Mississauga, Ontario L4W 4Y4
Phone: 905.361.9505
Fax: 905.629.4959
sthompson@ymbiosciences.com